Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000357097-16-000147
Filing Date
2016-05-05
Accepted
2016-05-05 08:02:06
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q fcsc-201633110q.htm 10-Q 666746
2 EXHIBIT 31.1 fcsc-2016331ex311.htm EX-31.1 9288
3 EXHIBIT 31.2 fcsc-2016331ex312.htm EX-31.2 9321
4 EXHIBIT 32.1 fcsc-2016331ex321.htm EX-32.1 6339
5 EXHIBIT 32.2 fcsc-2016331ex322.htm EX-32.2 6358
12 fcscpipeline042616.jpg GRAPHIC 82359
13 fibrocelllogocolorwdesk.jpg GRAPHIC 74382
  Complete submission text file 0000357097-16-000147.txt   3779114

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fcsc-20160331.xml EX-101.INS 640756
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20160331.xsd EX-101.SCH 32055
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20160331_cal.xml EX-101.CAL 45016
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20160331_def.xml EX-101.DEF 118375
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20160331_lab.xml EX-101.LAB 443596
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20160331_pre.xml EX-101.PRE 235021
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 161621631
SIC: 2834 Pharmaceutical Preparations